Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MAIA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
5 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bullish
Last trade: buy 29 days ago
Red flags: 4
36 filers reported a long position in MAIA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Solas Capital Management, LLC | $4.4M | 3M | -29.5% |
| Alyeska Investment Group, L.P. | $3.6M | 2.5M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.5M | 2.4M | +16.4% |
| 683 Capital Management, LLC | $1.5M | 1.1M | Unchanged |
| Centric Wealth Management | $1.1M | 796.7K | Unchanged |
| Cable Car Capital, LP | $741K | 514.6K | -20.7% |
| GEODE CAPITAL MANAGEMENT, LLC | $726.6K | 504.4K | +39.9% |
| Bleichroeder LP | $720K | 500K | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $598.6K | 415.7K | New |
| BlackRock, Inc. | $580.3K | 403K | +214.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.